Core Viewpoint - Li Auto Inc. (02015.HK) has announced a share repurchase plan authorized by its board, allowing the company to repurchase up to $1 billion of its Class A ordinary shares and/or American Depositary Shares from March 24, 2026, to March 31, 2027 [1] Group 1 - The share repurchase plan is set to enhance shareholder value and reflects the company's confidence in its financial position [1] - The repurchase will be executed within a specified timeframe, indicating a strategic approach to capital management [1] - The total value of the repurchase program is capped at $1 billion, showcasing the company's commitment to returning capital to shareholders [1]

Core Viewpoint - China Jinmao (00817.HK) reported a revenue of 59.371 billion RMB for the year ending December 31, 2025, representing a year-on-year increase of 1% [1] - The company emphasizes technological innovation and aims to strengthen its competitive edge in the real estate sector through a focus on building technology and sustainable practices [1] Financial Performance - Revenue reached 59.371 billion RMB, up 1% year-on-year [1] - Gross profit was 9.221 billion RMB, reflecting a 7% increase year-on-year [1] - Profit attributable to owners was 1.253 billion RMB, an 18% increase year-on-year [1] - Core profit attributable to owners was 1.363 billion RMB, showing a 2% increase year-on-year [1] - Basic earnings per share were 0.0438 RMB [1] Strategic Focus - The company is concentrating on building technology and aims to cultivate "unicorn" businesses through technological innovation [1] - China Jinmao is enhancing its one-stop service model from design consultation to operational management, focusing on green, energy-efficient, smart, comfortable, and healthy housing [1] - The smart energy segment is focused on comprehensive energy services and green big data center operations, aiming to improve operational efficiency and contribute to environmental sustainability goals [1]

Core Viewpoint - Jiutai Bonda Energy (02798.HK) reported a significant decline in annual performance for the year ending December 31, 2025, with revenues expected to be approximately RMB 1.206 billion, a decrease of about 29.3% compared to RMB 1.706 billion in 2024 [1] Financial Performance - The total loss and comprehensive expenses for the year are approximately RMB 198 million, contrasting with a profit and comprehensive income of about RMB 440 million in 2024 [1] - Basic loss per share is expected to be around RMB 0.1236, compared to earnings per share of RMB 0.2751 in 2024 [1] - The company does not recommend declaring a final dividend for the year ending December 31, 2025, while no dividend was declared in 2024 [1] Product Strategy - The company continues to focus on premium coal as its main product, maintaining a strategy to stabilize the proportion of premium coal in its product mix [1] - Revenue generated from premium coal sales is expected to account for approximately 86.8% of total revenue for the year ending December 31, 2025, down from about 90.9% in 2024, indicating a slight decrease in revenue contribution from this segment [1]

格隆汇3月24日丨昆仑能源(00135.HK)宣布，独立非执行董事辛定华，即公司审核委员会主席、薪酬委 员会及提名委员会的成员，已获委任为首席独立非执行董事，自2026年3月24日起生效。 ...

Core Viewpoint - The launch of Pemafibrate (brand name: Paireda®) by Hoshino Corporation on Alibaba Health marks the first official online availability of this next-generation selective PPARα modulator in China, providing a new treatment option for patients with hypertriglyceridemia (HTG) [1][5]. Group 1: Product Overview - Pemafibrate has been approved by the National Medical Products Administration since April 2025 and is now available to patients through an authorized e-commerce platform [1]. - The drug has been on the market in Japan for nine years and is recognized for its efficacy in lowering triglycerides while ensuring liver and kidney safety [1][5]. Group 2: Clinical Significance - Hypertriglyceridemia is prevalent in China, with a reported incidence rate of 15% to 22.4%, yet treatment and control rates are low at 11.6% and 5.4%, respectively [3]. - Each 1 mmol/L increase in triglyceride levels raises the risk of microvascular events by 35% and the risk of type 2 diabetes by 81% [3]. - Pemafibrate demonstrates a 2500-fold stronger activation effect on PPARα compared to traditional fibrates, with a clinical trial showing a 51.8% reduction in triglycerides at a dosage of 0.4 mg/day [3]. Group 3: Target Population - Pemafibrate is suitable for adult patients with non-familial hypertriglyceridemia, particularly those with poor dietary control, diabetes, or fatty liver, and those not achieving triglyceride targets while on statins [4][5]. - The drug has received recognition from various authoritative guidelines, including the 2023 Chinese Lipid Management Guidelines and the European Society of Cardiology guidelines, confirming its efficacy and safety [5].

Core Viewpoint - China Resources Beer reported a revenue of 37.985 billion yuan for 2025, an increase of 6.537 billion yuan compared to 31.448 billion yuan in 2020, with a net profit attributable to shareholders of 5.724 billion yuan, reflecting a year-on-year increase of 19.6% [1][3] Group 1: Financial Performance - The net cash inflow from operating activities for 2025 increased by 2.9% to 7.127 billion yuan, demonstrating the company's ability to create business value [3] - The dividend per share for 2025 was 1.021 yuan, a year-on-year increase of 34.3%, with a payout ratio rising to 98.2% [3] - The beer business maintained stable revenue of approximately 36.489 billion yuan, with a gross margin increase of 1.4 percentage points to 42.5% [8] Group 2: Strategic Initiatives - The company is focusing on a high-end strategy, with beer sales reaching approximately 11.03 million kiloliters in 2025, a year-on-year increase of 1.4% [7] - The growth in mid-to-high-end beer products is attributed to a shift in consumer preferences towards quality over quantity, creating new growth opportunities [4] - The company has launched innovative products such as Belgian-style white beer and black beer, as well as health-oriented products like "Zhang Zhongjing Medicinal Beer" and "Oyster Peptide Beer" [12][14] Group 3: Market Positioning - China Resources Beer is recognized as a leader in the high-end strategy, with nearly 25% of overall sales coming from mid-to-high-end beer products [8] - The company is actively expanding its multi-category layout, responding to diverse consumer demands through innovative product offerings [10] - The company has established strategic partnerships with major online platforms to capture the growing online consumption market, particularly targeting the Z generation [17] Group 4: Future Outlook - The company plans to deepen its integration into the Guangdong-Hong Kong-Macao Greater Bay Area by relocating its headquarters to Shenzhen, leveraging regional advantages for digital transformation [18] - The white liquor business reported a revenue of 1.496 billion yuan in 2025, with a resilient profit of 264 million yuan after excluding goodwill impairment [19] - The company aims to adapt to market changes by focusing on low-alcohol products and enhancing consumer engagement with its key product lines [19]

（文章来源：北京商报） 北京商报讯3月24日，中国金茂发布2025年度业绩公告显示，2025年中国金茂收入593.71亿元，同比增 长1%。毛利92.21亿元，同比增长7%；公司所有者应占溢利12.53亿元，同比增长18%；新增融资平均成 本降至2.75%。 管理层在业绩会上表示，上年度公司债务结构进一步优化，低融资成本的开发贷及经营贷占比提升至约 50%，外币债务占比持续下降至20%，财务安全性增强。截至报告期末，公司在手未动用银行授信超过 700亿元，资金储备充足。 ...

Core Viewpoint - Nongfu Spring (09633.HK) reported a total revenue of RMB 52.553 billion for the fiscal year ending December 31, 2025, representing a year-on-year increase of 22.5% [1] - The net profit attributable to shareholders was RMB 15.868 billion, up 30.9% year-on-year, with basic earnings per share of RMB 1.411, also reflecting a 30.9% increase [1] - A final dividend of RMB 0.99 per ordinary share is proposed [1] Group 1 - The drinking water business of the company saw a revenue recovery, generating RMB 18.709 billion in 2025, which is a 17.3% increase compared to 2024 [1] - Since 1996, the company has adhered to the practice of building factories at water source locations for bottling [1] - In 2025, the company added three new water sources: Hunan Badagong Mountain, Sichuan Longmen Mountain, and Tibet Nyainqentanglha Mountain, bringing the total to sixteen premium water sources nationwide [1] Group 2 - The company has opened its factories to consumers, allowing them to experience the high-quality source assurance of Nongfu Spring [1] - The company emphasizes the importance of mineral elements in water for health and believes that the growth of the drinking water business will align with the establishment of consumer health drinking concepts [1] - As the company approaches its 30th anniversary in 2026, it aims to adopt a strategy of "stability, gradualness, and long-term vision" to build trust and foster a future of mutual prosperity with society [1]

Core Viewpoint - Microsoft is accelerating its expansion in AI infrastructure by acquiring a data center project in Texas that was previously abandoned by Oracle and OpenAI, marking a significant move in the AI data center competition [1][2]. Group 1: Microsoft’s Acquisition - Microsoft has agreed to lease a data center project in Abilene, Texas, which has a capacity of approximately 700 megawatts, previously developed by Oracle and OpenAI [1]. - The deal was made with developer Crusoe, allowing Microsoft to establish a presence in a facility that will now host both Microsoft and Oracle, its competitors in the cloud computing and AI markets [1][3]. Group 2: Background of the Project - Negotiations between Oracle and OpenAI for the Abilene project broke down due to financing disputes and changing demands from OpenAI, leading to the project's abandonment by both companies [2]. - Meta Platforms also explored leasing the site but ultimately did not proceed, leaving the opportunity open for Microsoft [2]. Group 3: Microsoft’s Strategic Shift - This acquisition is part of Microsoft's broader strategy to rapidly expand its cloud computing and AI infrastructure, having signed approximately $50 billion in data center leasing commitments in the recent quarter to meet customer demand and support internal AI development [3]. - The transaction signifies a notable shift in Microsoft's strategy, as it had previously paused several data center projects about a year ago [3]. Group 4: Collaboration with NVIDIA - Microsoft and NVIDIA have announced a collaboration focused on AI tools for nuclear energy licensing and design [4].

Group 1 - Cathay Pacific Airways flight CX162 from Sydney to Hong Kong experienced a medical emergency on March 23, resulting in the death of a 56-year-old female passenger of Indian nationality [2][5][6] - The airline's crew provided immediate medical assistance and requested an emergency landing, with the aircraft landing safely and the passenger being transported to North Lantau Hospital, where she was later pronounced dead [5][6][7] - Cathay Pacific expressed deep condolences to the family of the deceased passenger and is cooperating with the ongoing investigation by the Hong Kong police regarding the cause of death [6][7] Group 2 - The flight CX162 was scheduled to depart from Sydney Kingsford Smith Airport at 11:05 AM local time and was set to arrive at Hong Kong International Airport at 5:30 PM, ultimately arriving 7 minutes early [7]